Cavrotolimod sodium is an immunostimulatory spherical nucleic acid (SNA) modified with type B CpG oligonucleotides designed to agonize TLR9 and elicit immune responses useful in oncology applications.
Molecular Weight:
9670.31
Formula:
C300H399N71Na24O161P26S23
Target:
Toll-like Receptor (TLR)
Application Notes:
Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted
